Active Ingredients (In Each Extended-Release Tablet)
Guaifenesin 1200 mg
Pseudoephedrine HCl 120 mg
The following Structured Product Label (SPL) was submitted to the FDA by Cvs Woonsocket Prescription Center, Incorporated for the product Mucus D (NDC 51316-345). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients (in each extended-release tablet), purposes, uses, do not use, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Guaifenesin 1200 mg
Pseudoephedrine HCl 120 mg
Expectorant
Nasal Decongestant
if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
carbomer homopolymer type B, colloidal silicon dioxide, FD&C yellow #6 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate
CVS™
12 HR
actual size
Maximum Strength
Mucus-D
Guaifenesin & Pseudoephedrine Hydrochloride
Extended-Release Tablets
1200 mg / 120 mg
Expectorant, Nasal Decongestant
Compare to Maximum Strength Mucinex® D active ingredients
Clears Nasal & Sinus Congestion
Thins & Loosens Mucus
Immediate & Extended Release
Relieves Nasal & Chest Congestion
24 EXTENDED-RELEASE TABLETS
* Please review the disclaimer below.